CRF announces featured clinical trials to be presented at TCT 2009 in San Francisco

WHAT:
A series of Featured Clinical Trials will be presented at Transcatheter Cardiovascular Therapeutics (TCT), in addition to late-breaking clinical trials. These featured clinical trials represent groundbreaking research and will yield data and insight that will further the field of interventional cardiology.

WHEN:
The TCT Featured Clinical Trials will be presented on September 24, 2009 from 2:00 - 6:00 pm.

Session I. Drug-Eluting Stents

• ZEST: Final Angiographic and IVUS Results From a Large-Scale Randomized Trial of Zotarolimus-Eluting, Sirolimus-Eluting and Paclitaxel-Eluting Stents

  Cheol Whan Lee, MD
  

• CEREA-DES: A Prospective Randomized Trial of Corticosteroids in Patients Undergoing Stent Implantation

  Flavio L Ribichini, MD
  

• STATINS PRE-PCI: A Prospective Randomized Trial of Statins Prior to Stent Implantation in Patients with Stable Angina

  Josef Veselka, MD, PhD
  

• NEVO RES-ELUTION I QOL: Formal Quality-of-Life Assessment from a Prospective Randomized Trial of a Novel Sirolimus-Eluting Stent and a Paclitaxel-Eluting Stent

  John A. Spertus, MD
  

• CILOTAX: A Prospective, Randomized, Controlled Trial of a Stent Eluting Cilostazol and Paclitaxel

  Cheol Whan Lee, MD
  

• BIOFREEDOM: A Prospective Randomized Trial of a Polymer-Free Biolimus A9-Eluting Stent

  Eberhard Grube, MD

Session II. ACS Therapies and Novel Imaging Approaches

• MISTRAL: A Prospective Randomized Trial of Ambulance-Initiated vs. Cath Lab-Initiated Intravenous Abciximab in Patients with STEMI

  Patrick Ohlmann, MD, PhD
  

• COCKTAIL: A Prospective Randomized Trial of Intracoronary Abciximab Infusion in Patients with Thrombotic Lesions Assessed by OCT
  Francesco Prati, MD
  
• NO REFLOW: A Prospective Randomized Trial of Intracoronary vs. Guide Catheter Infusion of Nitrates vs. Calcium Channel Blockers in Patients with No Reflow After Primary PCI in STEMI

  Junbo Ge, MD
  

• OCTAMI: A Prospective Randomized Trial of Zotarolimus-Eluting and Bare-Metal Stents in STEMI Assessed by OCT

  Giulio Guagliumi, MD

Session III. End-Stage, Structural Heart and Endovascular Intervention

• The Canadian Transcatheter Aortic Valve Implantation Program: Acute and Late Follow-up from a Multicenter Consecutive Series of Patients with Inoperable or High-Surgical Risk Aortic Stenosis

  Josep Rodes-Cabau, MD
  

• CROSS-CLI: A Prospective Multicenter Registry of Ultrasound-Facilitated Recanalization of Peripheral Chronic Total Occlusions

  David E. Allie, MD
  

• ARMOUR: A Prospective, Nonrandomized Study of the Mo.Ma Proximal Cerebral Protection Device in High Surgical Risk Subjects Undergoing Carotid Artery Stenting

  Gary M. Ansel, MD
  

• PROVASA: A Prospective, Randomized, Placebo-Controlled Trial of Intra-Arterial Progenitor Cell Transplantation of Bone Marrow Mononuclear Cells in Patients with Peripheral Arterial Occlusive Disease

  Dirk H. Walter, MD
  

• ACT34-CMI: One-Year Results from a Prospective, Randomized, Placebo-Controlled Phase II Trial of CD34+ Cells in Patients with Refractory Angina

  Douglas W. Losordo, MD

WHERE:
The Moscone Center
San Francisco, CA

Source: Cardiovascular Research Foundation